Current evidence on GnRH agonist pretreatment before frozen embryo transfer and pregnancy outcomes in women with adenomyosis: a systematic review and meta-analysis
Systematic review / meta-analysis
preprint
OA: green
CC0
Abstract
Abstract Adenomyosis is increasingly recognized as an important cause of infertility and reduced success rates in assisted reproductive technology (ART). Women with adenomyosis undergoing frozen embryo transfer (FET) have lower implantation and live birth rates compared to women without the disease. Gonadotropin-releasing hormone agonist (GnRH-a) pretreatment before FET has been proposed to improve reproductive outcomes by suppressing adenomyotic activity and enhancing endometrial receptivity; however, published studies have reported conflicting findings. The objective of this review was to evaluate the current evidence regarding the effectiveness of GnRH-a pretreatment before FET in women with adenomyosis. A systematic search of MEDLINE, EMBASE, Cochrane Library, Web of Science, and SCOPUS was performed up to November 9, 2024. Ten eligible studies, including randomized controlled trials and retrospective cohort studies, were identified. Outcomes included live birth, clinical pregnancy, biochemical pregnancy, and miscarriage rates. Although none of the pooled analyses reached statistical significance, GnRH-a pretreatment showed a consistent trend toward improved live birth and clinical pregnancy outcomes. The odds ratio for live birth was 1.47 per cycle and 1.23 per patient, favouring pretreatment. Clinical pregnancy rates also tended to improve, while biochemical pregnancy and miscarriage rates remained similar between groups. Current evidence suggests that GnRH-a pretreatment before FET may improve reproductive outcomes in women with adenomyosis, particularly live birth rates, although the quality of evidence remains limited by heterogeneity, retrospective study design, and inconsistent diagnostic criteria. These findings support the potential role of GnRH-a pretreatment in selected patients while highlighting the need for large, well-designed randomized controlled trials to establish clear clinical recommendations.
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (32)
- Adenomyosis: the pathophysiology of an oestrogen-dependent disease via openalex
- Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy via openalex
- Correlation of adenomyosis features to live birth rates after the first IVF/ICSI treatment, when using the revised Morphological Uterus Sonographic Assessment group definitions via openalex
- Effect of Gonadotropin-Releasing Hormone Agonist Pre-Treatment on Outcomes of Fresh and Frozen Embryo Transfers in Women With Adenomyosis: A Retrospective Cohort Study With Literature Review via openalex
- Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis via openalex
- Efficacy of Hormonal Therapies for Decreasing Uterine Volume in Patients with Adenomyosis via openalex
- GnRH agonist improves pregnancy outcome in mice with induced adenomyosis by restoring endometrial receptivity via openalex
- Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis via openalex
- P-312 Effect on pregnancy outcomes of depot GnRH agonist pre-treatment before frozen-thawed embryo transfer cycles in patients with adenomyosis via openalex
- Pregnancy outcomes among women with endometriosis and fibroids: registry linkage study in Massachusetts via openalex
- Role of ultrasonography in the evaluation of disease severity and treatment efficacy in adenomyosis via openalex
- W3204011092 via openalex
- W4240484632 via openalex
- W4246342947 via openalex
- W4308179087 via openalex
- W4328135802 via openalex
- W4387048224 via openalex
- W4402404917 via openalex
- W4402928455 via openalex
- W4405201724 via openalex
- W1784175517 via openalex
- W4409773416 via openalex
- W1897910008 via openalex
- W2515052691 via openalex
- W2531269403 via openalex
- W2560438049 via openalex
- W2586468683 via openalex
- W2970684805 via openalex
- W3026284030 via openalex
- W3048586051 via openalex
- W3118615836 via openalex
- W3184973186 via openalex
Source provenance
- europepmc
- last seen: 2026-11-19T08:37:55.746041+00:00
- openalex
- last seen: 2026-11-19T06:04:33.792782+00:00
License: CC0
· commercial use OK